COVID-19 was first reported in Wuhan, China in December 2019 [@b0005]. The infectious disease has spread rapidly and was upgraded by WHO to be a pandemic. It commonly presents as fever, dry cough, and dyspnea. In a minor proportion of patients as the disease progresses, it may lead to severe alveolar damage-causing respiratory distress, which can culminate in mortality [@b0010]. The main route of human to human transmission has been suggested to occur by respiratory droplets released by the infected [@b0015], which has necessitated social distancing. Despite numerous measures by health agencies the disease continues to afflict the human race. Understandably, the past couple of months have seen a surge in the number of articles published on SARS-corona virus-2. These articles largely consist of clinical case reports, molecular profiling of the virus, bio-informatic analysis, and hypothesis. Among the hypothesis, the focus has largely been on identifying high-risk group, decoding pathogenic pathways, and in formulating therapeutic strategies.

We present a hypothesis to recognize a potentially high-risk group and to strategize a prophylactic measure to reduce the risk of virus infection in the specific group.

Hypothesis {#s0005}
==========

Studies including bio-informatic analysis have shown the presence of angiotensin-converting enzyme 2 (ACE2) receptors in oral mucosa, including the tongue, buccal mucosa, and gingiva [@b0020]. Similar to SARS-corona virus-1, even the SARS-corona virus-2 exhibits affinity towards ACE2 receptors [@b0010]. Thus, oral mucosa could be a possible route for SARS-corona virus-2 infection. Oral mucosa in pathological states such as chronic periodontitis/oral cancer has shown to exhibit higher levels of osteopontin, which in turn can activate the p38 mitogen-activated protein kinase, stimulating nuclear factor-kappa B signaling and elevating the level of the protease furin [@b0025], [@b0030], [@b0035]. In addition to furin, another protease cathepsin L is also elevated in chronic periodontitis and oral cancer, which in turn could be a result of the interleukin 6 mediated activation of the caveolin-1 mediated JNK-AP-1 signaling pathway [@b0040], [@b0045], [@b0050]. Both furin and cathepsin play a major role in enabling the SARS-corona virus-2 to infect the host cells as elaborated in the following steps:1)Furin pre-cleaves the S glycoprotein of the SARS-corona virus-2 into S1 and S2 subunits [@b0055], [@b0060].2)Following the pre-cleavage of the S glycoprotein, the receptor-binding domain (RBD) of the S1 subunit attaches itself to the angiotensin-converting enzyme 2 (ACE2) present in the host cells [@b0065].3)Following binding of the S1 subunit to the ACE-2 receptors, the virus fuses with the host cell in two mechanisms: (a) endosomal fusion which is mediated by cysteine proteases cathepsin B/L and (b) plasma membrane fusion mediated by the serine protease TMPRSS2. The heptad repeat (HR) 1 and the HR2 of the S2 subunit form a six-helix bundle (6-HB) fusion core. The formation of this core brings the cell membrane of the virus and the host close allowing cell fusion and infection [@b0060], [@b0065].

Based on the above-mentioned data, it can be hypothesized that the increased protease levels in chronic periodontitis and oral cancer could potentially increase the risk of an oral mucosa mediated SARS-corona virus-2 infection ([Fig. 1](#f0005){ref-type="fig"} ). In addition to increasing proteases, chronic periodontitis, and oral cancer patients have also reported having a low melatonin level [@b0070], [@b0075]. Melatonin possesses anti-inflammatory, anti-oxidant properties [@b0065]. Also, melatonin has shown to inhibit cathepsin L [@b0080]. Thus, exogenous supplementation of the melatonin could aid in reducing the virus-induced inflammation, oxidative stress, and disrupting the cathepsin mediated fusion of virus and host cell.Fig. 1Oral mucosa mediated SARS-corona virus-2 infection in oral cancer/periodontitis patients.
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